Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

878.24
-18.7600-2.09%
Post-market: 875.00-3.2400-0.37%19:59 EDT
Volume:2.74M
Turnover:2.43B
Market Cap:830.27B
PE:38.27
High:900.83
Open:896.00
Low:877.11
Close:897.00
52wk High:1,133.95
52wk Low:623.78
Shares:945.38M
Float Shares:945.00M
Volume Ratio:0.95
T/O Rate:0.29%
Dividend:6.00
Dividend Rate:0.68%
EPS(TTM):22.95
EPS(LYR):22.95
ROE:101.16%
ROA:19.42%
PB:31.29
PE(LYR):38.27

Loading ...

INSTANT VIEW-Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say

Reuters
·
Feb 23

Eli Lilly Introduces New Zepbound Formulation with Single Pen for Monthly Dosage

Deep News
·
Feb 23

FDA approves Zepbound label expansion to include multi-dose KwikPen

Reuters
·
Feb 23

Zepbound (Tirzepatide), the Most Prescribed Weight Management Medication in 2025, NOW Available in Multi-Dose Kwikpen

THOMSON REUTERS
·
Feb 23

Lilly to launch multi-dose weight-loss drug device in US

Reuters
·
Feb 23

Eli Lilly: Zepbound Patients Can NOW Access All Doses in Either Multi-Dose Kwikpen or Single-Dose Vial Starting at $299 per Month for 2.5 Mg Dose

THOMSON REUTERS
·
Feb 23

Eli Lilly: Zepbound Kwikpen Is Available in 2.5 Mg, 5 Mg, 7.5 Mg, 10 Mg, 12.5 Mg, or 15 Mg Doses

THOMSON REUTERS
·
Feb 23

Eli Lilly: FDA Approved Label Expansion for Zepbound (Tirzepatide) to Include Four-Dose Single-Patient Use Kwikpen

THOMSON REUTERS
·
Feb 23

Sector Update: Health Care

MT Newswires Live
·
Feb 23

Pre-Market Update: Nasdaq Futures Drop 0.66% as Gold Prices Surge

Deep News
·
Feb 23

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Domino's, Novo Nordisk

Reuters
·
Feb 23

US STOCKS-Wall St futures decline as tariff uncertainty curbs risk appetite

Reuters
·
Feb 23

Rothschild & Co Redburn Adjusts PT on Eli Lilly to $875 From $830, Maintains Neutral Rating

MT Newswires Live
·
Feb 23

Novo Nordisk's Obesity Drug Falls Short Against Eli Lilly's in Copenhagen Trial

Reuters
·
Feb 23

Eli Lilly Shares Rise 2.1% Premarket After Novo Nordisk's Obesity Drug Falls Short Against Eli Lilly's in Copenhagen Trial

THOMSON REUTERS
·
Feb 23

Ratings Weekly | Nvidia, Apple, Microsoft, Amazon, Netflix, Palantir, Broadcom, CoreWeave, Carvana and More to Watch

Tiger Newspress
·
Feb 22

Bridgewater Associates' 4Q Buying and Selling -- Barron's

Dow Jones
·
Feb 21

Eli Lilly & Co. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Feb 21

Top Calls on Wall Street: Apple, Microsoft, Netflix, Broadcom, CoreWeave, Eli Lilly, Walmart, and More

Tiger Newspress
·
Feb 20

Eli Lilly Initiated at Overweight by Barclays

Dow Jones
·
Feb 20